| Chair | Theodore F. Reiss, MD, MBE, ATSF | Cambridge, MA |
| Vice Chair | Linda Nici, MD | Providence, RI |
| Committee Member | Chris Blango | Wilmington, DE |
| Committee Member - CCR Representative | Don Hayes, MD, MS, MEd, ATSF | Cincinnati, OH |
| Committee Member | Greg Lund | Kansas City, MO |
| Committee Member | Gregory P. Downey, MD, ATSF, FRCP(C) | Denver, CO |
| Committee Member | John H. Hansen-Flaschen, MD, ATSF | Philadelphia, PA |
| Committee Member | Lynn M. Schnapp, MD, ATSF | Madison, WI |
| Committee Member - PAR Representative | Michele Manion, BS | Minneapolis, MN |
| Committee Member | Nicholas S. Hill, MD | Boston, MA |
| Committee Member | Richard K. Murray, MD | San Francisco, CA |
| Committee Member | Stuart Loesch, MBA | Kenilworth, NJ |
| Staff | Michelle Turenne | New York, NY |
| Staff | Ally Felix | New York, NY |
| Staff | Melinda Garcia | New York, NY |
The ATS Funds for the Future Committee generates charitable funding support to advance the careers of talented individuals committed to basic, clinical and translational research and training of the next generation of health professionals.
The Committee is comprised of ATS members and non-members who have an interest, commitment and/or professional experience in fundraising. Its goals are to cultivate fundraising both within and outside the Society’s membership, develop new approaches to fundraising and advance careers at all stages.
The chair of the FFF Committee is a member of the ATS Board of Directors. The work of the Committee should help move the society’s future plans forward.
Benchmarks 2020-2021:
• Refine the existing strategic plan and mission with consideration to the Society’s 125th Anniversary in 2030;
• Ensure that all funds raised are used as the donors intended;
• Increase funds and diversify the fundraising base to optimize support of innovative research, clinical practice and training;
• Collaborate with the ATS PAR to support early career professionals and in providing research grants to talented investigators aimed at growing our scientific understanding and improving the quality of life of patients;
• Develop partnerships with other philanthropic entities that can improve the fundraising abilities of the ATS;
• Working with Executive Staff, revisit the separation language from the American Lung Association and work toward either a collaborative fund-raising effort or the freedom from 20-year restrictions that prohibit public fundraising and use of the word “lung.”
